The Journal of Organic Chemistry
Article
1
Data for pseudorotaxane endoperoxide 4EP-ext: H NMR (600
MHz, CDCl3, 0 °C) δ 9.26 (s, 2H), 8.55−8.58 (m, 4H), 8.43 (s, 2H),
7.86 (dd, J = 3.2 Hz, J = 6.8 Hz, 2H), 7.76 (dd, J = 3.2 Hz, J = 7.0 Hz,
2H), 7.45 (t, J = 7.6 Hz, 4H), 7.38 (t, J = 7.3 Hz, 2H), 7.34 (d, J = 9.1
Hz, 2H), 7.28−7.32 (m, 6H), 7.17 (dd, J = 3.5 Hz, J = 5.0 Hz, 2H),
7.03 (dd, J = 3.8 Hz, J = 4.7 Hz, 2H), 6.98 (d, J = 9.1 Hz, 2H), 6.93
(dd, J = 2.9 Hz, J = 7.0 Hz, 2H), 6.60 (d, J = 9.1 Hz, 2H), 6.48 (dd, J =
2.9 Hz, J = 7.0 Hz, 2H), 6.39 (dd, J = 2.9 Hz, J = 5.6 Hz, 2H), 6.33
(dd, J = 2.9 Hz, J = 5.1 Hz, 2H), 5.82 (d, J = 9.4 Hz, 2H), 5.74 (dd, J =
6.8 Hz, J = 15.0 Hz, 2H), 5.01 (d, J = 15.0 Hz, 2H), 4.93 (s, 4H), 4.48
(dd, J = 6.7 Hz, J = 13.8 Hz, 2H), 4.03 (d, J = 13.8 Hz, 2H), 3.63−3.71
(m, 2H), 3.35−3.44 (m, 2H), 1.70−1.92 (m, 8H), 1.50 (s, 18H); 13C
NMR (150 MHz, CDCl3, 0 °C) δ 184.2, 180.1, 176.7, 168.0, 167.8,
153.9, 153.8, 152.8, 136.3, 135.9, 135.3, 134.2, 134.1, 133.8, 133.1,
130.8, 130.6, 130.3, 130.1, 130.0, 129.8, 129.4, 128.9, 128.2, 126.4,
126.3, 124.8, 124.7, 123.7, 122.8, 122.2, 121.6, 120.4, 115.7, 112.4,
111.8, 81.2, 55.2, 50.2, 38.7, 37.0, 35.4, 31.5, 27.6, 26.7; HRMS (ESI-
TOF) calcd for C92H87N6O8 [M + H] 1403.6580, found 1403.6587.
(11.4 mg, 26.3 μmol) in chloroform (5 mL). N,N-Diisopropylethyl-
amine (2 drops) and tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]-
amine copper(I)bromide (2.5 mg, 3.7 μmol) were added, and the
reaction was stirred at rt for 16 h. The reaction was washed with
saturated aqueous EDTA solution (5 mL), and the organic layer was
collected and evaporated under reduced pressure. The crude product
that was purified using silica gel column chromatography, using a
20:80 to 50:50 (v/v) ethyl acetate/chloroform eluent gradient to
obtain pure 15 (84% yield, 13.0 mg, 5.64 μmol) as a green amorphous
solid: 1H NMR (600 MHz, CDCl3) δ 9.39 (t, J = 1.7 Hz, 2H), 8.55 (d,
J = 0.9 Hz, 4H), 8.27 (t, J = 4.4 Hz, 4H), 7.77 (dd, J = 3.5 Hz, J = 7.1
Hz, 8H), 7.22−7.27 (m,16H), 7.16−7.22 (m, 16H), 7.09 (d, J = 8.8
Hz, 4H), 7.03 (d, J = 9.4 Hz, 4H), 6.74 (d, J = 8.8 Hz, 4H), 6.67 (dd, J
= 3.2 Hz, J = 7.0 Hz, 8H), 6.09 (d, J = 9.4 Hz, 4H), 5.25 (d, J = 3.8 Hz,
8H), 4.38 (t, J = 7.3 Hz, 4H), 3.94 (t, J = 5.8 Hz, 4H), 3.46 (t, J = 7.9
Hz, 4H), 3.13 (s, 6H), 2.70 (t, J = 7.9 Hz, 4H), 2.08 (pent, J = 7.4 Hz,
4H), 1.77 (pent, J = 5.8 Hz, 4H), 1.65−1.73 (m, 4H), 1.54 (s, 18H),
1.37−1.44 (m, 20H); 13C NMR (150 MHz, CDCl3) δ 184.3, 179.6,
167.3, 156.8, 154.0, 153.1, 148.6, 147.2, 139.3, 133.5, 133.0, 132.4,
131.3, 130.6, 129.2, 128.8, 127.6, 126.1, 126.0, 124.2, 122.8, 120.7,
117.3, 113.3, 111.6, 66.9, 64.5, 53.0, 50.0, 39.2, 38.2, 35.6, 31.7, 29.9,
29.8, 29.7, 29.6, 29.5, 29.4, 27.8, 27.5, 27.2, 26.5, 25.9; HRMS (ESI-
TOF) calcd for C154H159N12O8 [M2+] 1152.1196, found 1152.1183.
1
Data for pseudorotaxane endoperoxide 5EP-ext: H NMR (600
MHz, CDCl3) δ 9.24 (s, 2H), 8.62 (d, J = 6.4 Hz, 2H), 8.59 (t, J = 1.6
Hz, 2H), 8.45 (t, J = 1.8 Hz, 2H), 7.87 (dd, J = 3.2 Hz, J = 6.7 Hz,
2H), 7.80 (dd, J = 3.2 Hz, J = 6.8 Hz, 2H), 7.43−7.46 (m, 4H), 7.41
(d, J = 9.1 Hz, 2H), 7.37 (t, J = 7.8 Hz, 2H), 7.30−7.32 (m, 4H), 7.21
(d, J = 7.3 Hz, 2H), 7.18 (dd, J = 3.2 Hz, J = 5.6 Hz, 2H), 7.16 (dd, J =
2.3 Hz, J = 6.2 Hz, 2H), 6.99−7.03 (m, 4H), 6.94 (dd, J = 2.9 Hz, J =
7.0 Hz, 2H), 6.63 (d, J = 9.4 Hz, 2H), 6.50 (dd, J = 2.9 Hz, J = 6.8 Hz,
2H), 6.39−6.41 (m, 4H), 5.87 (d, J = 9.4 Hz, 2H), 5.77 (dd, J = 7.1
Hz, J = 15.0 Hz, 2H), 5.04 (dd, J = 1.2 Hz, J = 14.6 Hz, 2H), 4.92 (s,
4H), 4.47 (dd, J = 6.5 Hz, J = 13.5 Hz, 2H), 4.04 (dd, J = 2.0 Hz, J =
13.5 Hz, 2H), 3.49 (t, J = 6.5 Hz, 4H), 1.82−1.86 (m, 2H), 1.74−1.78
(m. 4H), 1.51 (s, 18H).
1
Squaraine rotaxane endoperoxide 15EP-ext: H NMR (600
MHz, CDCl3) δ 9.25 (s, 2H), 8.66 (t, J = 4.1 Hz, 2H), 8.61 (t, J = 1.7
Hz, 2H), 8.47 (t, J = 1.7 Hz, 2H), 7.87 (dd, J = 3.2 Hz, J = 7.0 Hz,
4H), 7.22−7.28 (m,18H), 7.16−7.20 (m, 18H), 7.12 (dd, J = 3.2 Hz, J
= 5.6 Hz, 4H), 7.09 (d, J = 8.8 Hz, 4H), 6.76 (dd, J = 2.9 Hz, J = 7.0
Hz, 4H), 6.73 (d, J = 9.1 Hz, 4H), 6.43 (dd, J = 2.9 Hz, J = 5.6 Hz,
4H), 6.13 (d, J = 9.1 Hz, 4H), 5.42 (d, J = 4.1 Hz, 4H), 4.37 (t, J = 7.0
Hz, 4H), 4.25 (d, J = 4.1 Hz, 4H), 3.93 (t, J = 5.9 Hz, 4H), 3.45 (t, J =
7.9 Hz, 4H), 3.13 (s, 6H), 2.68 (t, J = 7.6 Hz, 4H), 2.07 (pent, J = 7.6
Hz, 4H), 1.77 (pent, J = 5.9 Hz, 4H), 1.62−1.71 (m, 8H), 1.52 (s,
18H), 1.38−1.42 (m, 8H), 1.32−1.37 (m, 12H); 13C NMR (150
MHz, CDCl3, 0 °C) δ 184.5, 178.4, 168.1, 167.8, 156.7, 153.7, 152.8,
148.6, 147.0, 139.2, 135.7, 134.0, 133.9, 133.2, 132.2, 131.2, 130.8,
130.6, 130.2, 129.9, 129.0, 127.6, 126.0, 125.5, 124.4, 122.8, 121.9,
120.7, 117.8, 113.1, 111.6, 81.2, 66.8, 64.3, 53.0, 50.0, 39.2, 38.7, 37.1,
35.5, 31.5, 29.9, 29.7, 29.6, 29.5, 29.4, 27.8, 27.5, 27.2, 26.3, 25.8, 22.9;
HRMS (ESI-TOF) calcd for C154H159N12O10 [M + H] 2336.2297,
found 2336.2312.
Monoendoperoxide Macrocycle 1EP. Endoperoxide pseudor-
otaxane 3EP (19 mg, 12 μmol) was dissolved in acetone (20 mL) and
allowed to dethread over 12 h at 5 °C. The resulting blue solution was
evaporated under reduced pressure and purified by silica gel column
chromatography. A 10:90 (v/v) ethyl acetate/chloroform eluent was
used to obtain 1EP (91% yield, 9.7 mg, 11 μmol) as a white solid. On
occasion, unoxidized macrocycle 1 contaminates the sample, which
can be removed via selective templation of 1 with squaraine 13 (1EP
does not complex 13). The resulting pseudorotaxane can be separated
from 1EP by silica gel column chromatography using a 20:20:60 (v/v/
v) ethyl acetate/hexanes/chloroform eluent to provide purified 1EP as
an amorphous white solid: 1H NMR (500 MHz, CDCl3) δ 8.41 (t, J =
2.2 Hz, 2H), 8.39 (dd, J = 3.4 Hz, J = 7.1 Hz, 4H), 8.34 (t, J = 1.8 Hz,
2H), 7.59 (dd, J = 3.2 Hz, J = 7.0 Hz, 4H), 7.37 (dd, J = 3.4 Hz, J = 5.6
Hz, 4H), 7.28 (t, J = 1.4 Hz, 2H), 7.20 (dd, J = 3.2 Hz, J = 5.6 Hz,
4H), 6.40 (t, J = 5.6 Hz, 2H), 6.36 (t, J = 4.0 Hz, 2H), 5.68 (d, J = 4.4
Hz, 4H), 4.81 (d, J = 5.8 Hz, 4H), 1.45 (s, 18H); 13C NMR (150
MHz, CDCl3) δ 167.2, 166.8, 153.7, 138.5, 133.8, 132.8, 130.6, 130.4,
130.0, 129.6, 128.3, 127.0, 124.9, 121.6, 119.1, 81.3, 38.6, 37.5, 31.4,
29.9; HRMS (ESI-TOF) calcd for C56H52N4O6Na [M + Na]
899.3761, found 899.3779.
1
Data for endoperoxide pseudorotaxane 5EP-int: H NMR (600
MHz, CDCl3) δ 9.53 (s, 2H), 8.74 (dd, J = 3.5 Hz, J = 6.5 Hz, 2H),
8.59 (t, J = 1.7 Hz, 2H), 8.45 (t, J = 1.7 Hz, 2H), 8.10 (dd, J = 3.8 Hz, J
= 8.2 Hz, 2H), 7.95 (dd, J = 3.8 Hz, J = 8.3 Hz, 2H), 7.75 (dd, J = 5.3
Hz, J = 9.4 Hz, 2H), 7.65 (d, J = 11.0 Hz, 2H), 7.41 (t, J = 7.7 Hz,
4H), 7.32−7.37 (m, 2H), 7.16−7.22 (m, 6H), 7.06 (dd, J = 3.2 Hz, J =
5.6 Hz, 2H), 6.92 (d, J = 7.3 Hz, 2H), 6.85 (dd, J = 2.9 Hz, J = 5.6 Hz,
2H), 6.79 (dd, J = 3.2 Hz, J = 5.6 Hz, 2H), 6.56 (dd, J = 2.9 Hz, J = 5.6
Hz, 2H), 6.38 (d, J = 9.7 Hz, 2H), 5.78 (dd, J = 7.0 Hz, J = 14.9 Hz,
2H), 5.67 (d, J = 9.1 Hz, 2H), 5.32 (d, J = 14.6 Hz, 2H), 5.10 (dd, J =
8.5 Hz, J = 15.2 Hz, 2H), 4.70 (s, 4H), 4.15 (d, J = 15.2 Hz, 2H), 3.31
(t, J = 5.6 Hz, 4H), 1.70−1.77 (m, 4H), 1.63−1.66 (m, 2H), 1.47 (s,
18H); 13C NMR (150 MHz, CDCl3) δ 186.1, 167.7, 166.4, 154.3,
154.1, 152.9, 139.6, 138.4, 136.3, 133.5, 133.3, 133.0, 132.9, 131.0,
130.8, 129.9, 129.5, 129.3, 129.2, 128.1, 127.3, 126.9, 126.8, 126.7,
126.3, 125.9, 125.0, 124.3, 122.2, 121.6, 121.3, 120.7, 112.5, 112.4,
80.6, 54.3, 48.1, 38.3, 36.9, 35.5, 31.6, 31.4, 26.3; HRMS (ESI-TOF)
calcd for C91H84N6O8K [M + K] 1427.5988, found 1428.5989.
Data for endoperoxide pseudorotaxane 14EP-ext: 1H NMR (600
MHz, CDCl3) δ 9.26 (t, J = 1.4 Hz, 2H), 8.67 (t, J = 4.4 Hz, 2H), 8.62
(t, J = 1.6 Hz, 2H), 8.48 (t, J = 1.5 Hz, 2H), 7.88 (dd, J = 3.2 Hz, J =
6.7 Hz, 4H), 7.22 (t, J = 4.6 Hz, 2H), 7.13 (dd, J = 3.2 Hz, J = 5.4 Hz,
4H), 6.77 (dd, J = 3.1 Hz, J = 6.9 Hz, 4H), 6.43 (dd, J = 2.9 Hz, J = 5.6
Hz, 4H), 6.14 (d, J = 9.4 Hz, 4H), 5.43 (d, J = 4.1 Hz, 4H), 4.28 (d, J
= 4.1 Hz, 4H), 3.47 (t, J = 7.7 Hz, 4H), 3.15 (s, 6H), 2.18 (td, J = 2.6
Hz, J = 7.3 Hz, 4H), 1.95 (t, J = 2.6 Hz, 2H), 1.68−1.73 (m, 4H),
1.62−1.68 (m, 4H), 1.53 (s, 18H), 1.30−1.38 (m, 20H).
Data for endoperoxide pseudorotaxane 14EP-int: 1H NMR (500
MHz, CDCl3) δ 9.62 (t, J = 1.6 Hz, 2H), 8.80 (t, J = 5.0 Hz, 2H), 8.64
(t, J = 1.8 Hz, 2H), 8.48 (t, J = 1.7 Hz, 2H), 8.05 (dd, J = 3.4 Hz, J =
7.0 Hz, 4H), 7.82 (t, J = 5.8 Hz, 2H), 7.46 (d, J = 8.8 Hz, 4H), 6.94
(dd, J = 3.2 Hz, J = 5.6 Hz, 4H), 6.89 (dd, J = 3.2 Hz, J = 7.0 Hz, 4H),
6.71 (dd, J = 3.1 Hz, J = 5.6 Hz, 4H), 5.92 (d, J = 8.4 Hz, 4H), 5.56 (d,
J = 4.4 Hz, 4H), 4.62 (br. s, 4H), 3.31 (t, J = 7.6 Hz, 4H), 2.99 (s, 6H),
2.19 (td, J = 2.6 Hz, J = 7.2 Hz, 4H), 1.94 (t, J = 2.6 Hz, 2H), 1.47−
1.56 (m, 8H), 1.52 (s, 18H), 1.30−1.38 (m, 20H); HRMS (ESI-TOF)
calcd for C96H105N6O8 [M + H] 1470.8021, found 1470.8037.
Squaraine Rotaxane 15. Pseudorotaxane 14 (9.6 mg, 6.7 μmol)
was combined with 1-(4-azidobutoxy)-4-(triphenylmethyl)benzene
Procedure for the Preparation of Triptycene Squaraine
Rotaxanes 17 and 18. Anthranilic acid (515 mg, 3.76 mmol) and
trichloroacetic acid (10 mg, 0.061 mmol) were dissolved in anhydrous
THF (20 mL) under a dry atmosphere of argon. The reaction was
cooled to −5 °C, and isopentyl nitrite (0.82 mL, 0.72 g, 6.1 mmol)
was added over 10 min. The mixture was stirred for 45 min at 0 °C
and then allowed to warm to room temperature for 1 h (a blast shield
was used during this sequence). The benzenediazonium-2-carboxylate
1128
dx.doi.org/10.1021/jo402564k | J. Org. Chem. 2014, 79, 1120−1130